The disclosed investors in the Series A round of financing are Emerson Collective, Illumina Ventures, and Quan Capital. B cells are a type of white blood cell that produces antibodies. Walking Fish is ...
MaxCyte signed a strategic platform license (SPL) with Walking Fish Therapeutics which focuses on B cell-based therapeutics. Walking Fish obtains non-exclusive clinical and commercial rights to use ...
View post: The Exact Arm and Shoulder Workout That Helped Glen Powell Pack On 20 Pounds of Muscle for 'The Running Man' The Exact Arm and Shoulder Workout That Helped Glen Powell Pack On 20 Pounds of ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Walking Fish Therapeutics, a leader in B cell therapeutics, today announced the completion of an oversubscribed Series A financing, raising a total of $73 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback